vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and QUINSTREET, INC (QNST). Click either name above to swap in a different company.
QUINSTREET, INC is the larger business by last-quarter revenue ($287.8M vs $284.0M, roughly 1.0× ACADIA PHARMACEUTICALS INC). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs 17.4%, a 78.9% gap on every dollar of revenue. On growth, ACADIA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.4% vs 1.9%). Over the past eight quarters, QUINSTREET, INC's revenue compounded faster (53.2% CAGR vs 17.5%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
QUINSTREET, INCQNSTEarnings & Financial Report
QuinStreet, Inc. is a publicly traded online marketing company based in Foster City, California. The company helps generate web traffic for clients by acquiring popular domain names.
ACAD vs QNST — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $284.0M | $287.8M |
| Net Profit | $273.6M | $50.2M |
| Gross Margin | 90.8% | 9.6% |
| Operating Margin | 6.1% | 0.4% |
| Net Margin | 96.3% | 17.4% |
| Revenue YoY | 9.4% | 1.9% |
| Net Profit YoY | 90.3% | 3342.5% |
| EPS (diluted) | $1.61 | $0.87 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $284.0M | $287.8M | ||
| Q3 25 | $278.6M | $285.9M | ||
| Q2 25 | $264.6M | — | ||
| Q1 25 | $244.3M | $269.8M | ||
| Q4 24 | $259.6M | $282.6M | ||
| Q3 24 | $250.4M | $279.2M | ||
| Q2 24 | $242.0M | $198.3M | ||
| Q1 24 | $205.8M | $168.6M |
| Q4 25 | $273.6M | $50.2M | ||
| Q3 25 | $71.8M | $4.5M | ||
| Q2 25 | $26.7M | — | ||
| Q1 25 | $19.0M | $4.4M | ||
| Q4 24 | $143.7M | $-1.5M | ||
| Q3 24 | $32.8M | $-1.4M | ||
| Q2 24 | $33.4M | $-2.2M | ||
| Q1 24 | $16.6M | $-7.0M |
| Q4 25 | 90.8% | 9.6% | ||
| Q3 25 | 92.2% | 9.4% | ||
| Q2 25 | 92.2% | — | ||
| Q1 25 | 91.7% | 10.3% | ||
| Q4 24 | 91.6% | 9.5% | ||
| Q3 24 | 92.5% | 10.2% | ||
| Q2 24 | 92.5% | 8.8% | ||
| Q1 24 | 88.8% | 8.5% |
| Q4 25 | 6.1% | 0.4% | ||
| Q3 25 | 12.8% | 1.7% | ||
| Q2 25 | 12.2% | — | ||
| Q1 25 | 7.9% | 1.8% | ||
| Q4 24 | 59.1% | -0.5% | ||
| Q3 24 | 12.6% | -0.4% | ||
| Q2 24 | 12.6% | -0.7% | ||
| Q1 24 | 7.4% | -3.2% |
| Q4 25 | 96.3% | 17.4% | ||
| Q3 25 | 25.8% | 1.6% | ||
| Q2 25 | 10.1% | — | ||
| Q1 25 | 7.8% | 1.6% | ||
| Q4 24 | 55.4% | -0.5% | ||
| Q3 24 | 13.1% | -0.5% | ||
| Q2 24 | 13.8% | -1.1% | ||
| Q1 24 | 8.0% | -4.2% |
| Q4 25 | $1.61 | $0.87 | ||
| Q3 25 | $0.42 | $0.08 | ||
| Q2 25 | $0.16 | — | ||
| Q1 25 | $0.11 | $0.08 | ||
| Q4 24 | $0.86 | $-0.03 | ||
| Q3 24 | $0.20 | $-0.02 | ||
| Q2 24 | $0.20 | $-0.04 | ||
| Q1 24 | $0.10 | $-0.13 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.7M | $107.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.2B | $294.4M |
| Total Assets | $1.6B | $493.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $177.7M | $107.0M | ||
| Q3 25 | $258.0M | $101.3M | ||
| Q2 25 | $253.6M | — | ||
| Q1 25 | $217.7M | $81.8M | ||
| Q4 24 | $319.6M | $57.8M | ||
| Q3 24 | $155.1M | $25.0M | ||
| Q2 24 | $177.1M | $50.5M | ||
| Q1 24 | $204.7M | $39.6M |
| Q4 25 | $1.2B | $294.4M | ||
| Q3 25 | $917.3M | $246.7M | ||
| Q2 25 | $822.4M | — | ||
| Q1 25 | $765.2M | $235.5M | ||
| Q4 24 | $732.8M | $224.3M | ||
| Q3 24 | $577.2M | $219.8M | ||
| Q2 24 | $516.7M | $216.8M | ||
| Q1 24 | $464.0M | $215.0M |
| Q4 25 | $1.6B | $493.0M | ||
| Q3 25 | $1.3B | $442.6M | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $1.1B | $417.2M | ||
| Q4 24 | $1.2B | $409.6M | ||
| Q3 24 | $976.9M | $401.2M | ||
| Q2 24 | $914.1M | $368.5M | ||
| Q1 24 | $855.1M | $349.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.7M | $21.6M |
| Free Cash FlowOCF − Capex | — | $20.7M |
| FCF MarginFCF / Revenue | — | 7.2% |
| Capex IntensityCapex / Revenue | — | 0.3% |
| Cash ConversionOCF / Net Profit | -0.18× | 0.43× |
| TTM Free Cash FlowTrailing 4 quarters | — | $106.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.7M | $21.6M | ||
| Q3 25 | $74.3M | $19.6M | ||
| Q2 25 | $64.0M | — | ||
| Q1 25 | $20.3M | $30.1M | ||
| Q4 24 | $40.4M | $38.7M | ||
| Q3 24 | $63.2M | $-13.7M | ||
| Q2 24 | $25.0M | $16.6M | ||
| Q1 24 | $29.1M | $4.1M |
| Q4 25 | — | $20.7M | ||
| Q3 25 | $73.9M | $18.4M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $29.5M | ||
| Q4 24 | — | $38.2M | ||
| Q3 24 | $63.2M | $-14.1M | ||
| Q2 24 | — | $15.4M | ||
| Q1 24 | — | $2.9M |
| Q4 25 | — | 7.2% | ||
| Q3 25 | 26.5% | 6.4% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 10.9% | ||
| Q4 24 | — | 13.5% | ||
| Q3 24 | 25.2% | -5.1% | ||
| Q2 24 | — | 7.8% | ||
| Q1 24 | — | 1.7% |
| Q4 25 | — | 0.3% | ||
| Q3 25 | 0.1% | 0.4% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | 0.0% | 0.2% | ||
| Q2 24 | — | 0.6% | ||
| Q1 24 | — | 0.7% |
| Q4 25 | -0.18× | 0.43× | ||
| Q3 25 | 1.03× | 4.32× | ||
| Q2 25 | 2.40× | — | ||
| Q1 25 | 1.07× | 6.82× | ||
| Q4 24 | 0.28× | — | ||
| Q3 24 | 1.93× | — | ||
| Q2 24 | 0.75× | — | ||
| Q1 24 | 1.76× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
QNST
| Financial Service | $216.8M | 75% |
| Home Services And Other Revenue | $71.0M | 25% |
